152 related articles for article (PubMed ID: 30187607)
1. A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA.
Vroling H; Oordt-Speets AM; Madeddu G; Babudieri S; Monarca R; O'Moore E; Vonk Noordegraaf-Schouten M; Wolff H; Montanari M; Hedrich D; Tavoschi L
J Viral Hepat; 2018 Dec; 25(12):1406-1422. PubMed ID: 30187607
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
3. Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.
Madeddu G; Vroling H; Oordt-Speets A; Babudieri S; O'Moore É; Noordegraaf MV; Monarca R; Lopalco PL; Hedrich D; Tavoschi L
Vaccine; 2019 Aug; 37(35):4906-4919. PubMed ID: 31327651
[TBL] [Abstract][Full Text] [Related]
4. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings.
Chen CP; Cheng CY; Zou H; Cheng CH; Cheng SH; Chen CK; Chen CH; Bair MJ
J Microbiol Immunol Infect; 2019 Aug; 52(4):556-562. PubMed ID: 30360951
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
European Union HCV Collaborators
Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
[TBL] [Abstract][Full Text] [Related]
8. The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review.
Greenaway C; Makarenko I; Chakra CNA; Alabdulkarim B; Christensen R; Palayew A; Tran A; Staub L; Pareek M; Meerpohl JJ; Noori T; Veldhuijzen I; Pottie K; Castelli F; Morton RL
Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30223539
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
[TBL] [Abstract][Full Text] [Related]
10. Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.
Tavoschi L; Vroling H; Madeddu G; Babudieri S; Monarca R; Vonk Noordegraaf-Schouten M; Beer N; Gomes Dias J; O'Moore É; Hedrich D; Oordt-Speets A
Epidemiol Rev; 2018 Jun; 40(1):105-120. PubMed ID: 29648594
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.
Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
BMC Public Health; 2020 Nov; 20(1):1670. PubMed ID: 33167912
[TBL] [Abstract][Full Text] [Related]
12. Family Practitioner-Directed Hepatitis C Therapy With Direct-Acting Antivirals Achieves High-Sustained Virologic Response in Prison Population.
Mokkarala S; Johnson C; Sarkar S; Rudas RJ
J Correct Health Care; 2019 Apr; 25(2):134-142. PubMed ID: 30866706
[TBL] [Abstract][Full Text] [Related]
13. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness, cost effectiveness and acceptability of community-based treatment of hepatitis C virus infection: A mixed method systematic review.
Pourmarzi D; Hall L; Hepworth J; Smirnov A; Rahman T; FitzGerald G
J Viral Hepat; 2019 Apr; 26(4):432-453. PubMed ID: 30516874
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
Han R; Zhou J; François C; Toumi M
BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
[TBL] [Abstract][Full Text] [Related]
16. Elimination of hepatitis C virus in a prison: An 18-year experience.
Nogales-Garcia M; Parraza Diez N; Vargas Axpe A; Velasco Garcia R; Larrabeiti-Etxebarria A; Roy Lopez-Cano I; Atrio Alvarez I; Lopez de Arcaute Trincado A; Fernandez Lopez de Vicuña EM; Saez de Adana Arroniz E; Martínez Martínez C; Portu Zapirain J
Enferm Infecc Microbiol Clin (Engl Ed); 2024 May; 42(5):236-241. PubMed ID: 37117143
[TBL] [Abstract][Full Text] [Related]
17. A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy.
Aspinall EJ; Mitchell W; Schofield J; Cairns A; Lamond S; Bramley P; Peters SE; Valerio H; Tomnay J; Goldberg DJ; Mills PR; Barclay ST; Fraser A; Dillon JF; Martin NK; Hickman M; Hutchinson SJ
J Viral Hepat; 2016 Dec; 23(12):1009-1016. PubMed ID: 27509844
[TBL] [Abstract][Full Text] [Related]
18. Treating hepatitis C in the prison population is cost-saving.
Tan JA; Joseph TA; Saab S
Hepatology; 2008 Nov; 48(5):1387-95. PubMed ID: 18924228
[TBL] [Abstract][Full Text] [Related]
19. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
20. A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison.
Palmer A; Papaluca T; Stoové M; Winter R; Pedrana A; Hellard M; Wilson D; Thompson A; Scott N;
Int J Drug Policy; 2021 Aug; 94():103203. PubMed ID: 33744667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
